Europe Archives - Page 44 of 93 - Journal for Clinical Studies

Current Edition

Europe

CRF Bracket Becomes a Leading Employer in Romania Two Years after Establishing Office as Demand for Trustworthy Global Support of eClinical Solutions Continues to Grow

Plymouth Meeting, PA – February 6, 2019: CRF Bracket is celebrating unprecedented success in Romania after opening an eClinical technology facility in the...

14 February 2019 Europe | news | Regional News

Continue Reading →

Europe

FDA approves Cablivi® (caplacizumab-yhdp), the first Nanobody®-based medicine, for adults with acquired thrombotic thrombocytopenic purpura (aTTP)

First medicine approved in the U.S. specifically for the treatment of aTTP, a rare blood-clotting disorderCablivi is the first U.S. approval for Sanofi's new rare bl...

14 February 2019 Europe | news | Regional News

Continue Reading →

Asia Pacific

Development progress in 2018 for acute ischemic stroke drugs will fuel market growth, says GlobalData

Activase (alteplase) is currently the only FDA-approved drug available for the treatment of acute ischemic stroke (AIS) in the 8MM*; however, novel drugs designed to...

Continue Reading →

Asia Pacific

Brand new type of cancer drug has potential to fill unmet needs in oncology market, says GlobalData

Following a study published in The Lancet Oncology regarding a brand new type of cancer drug that has shown promise in multiple cancer types in early Phase I/II tria...

Continue Reading →

Europe

4 of the Top 7 Global CROs Have Selected Veeva Vault eTMF as Their Enterprise Standard

BARCELONA, Spain — 13 February 2019 — Veeva Systems (NYSE:VEEV) today announced four of the world’s top seven largest CROs are standardizing on V...

14 February 2019 Europe | news | Regional News

Continue Reading →

Europe

SGS to Conduct its First Malaria Human Challenge Trial in Belgium

Antwerp, Belgium, February 12, 2019 SGS, a leading life-sciences, clinical and bioanalytical contract solutions provider, today announced that it will commence ...

14 February 2019 Europe | news | Regional News

Continue Reading →

Asia Pacific

Despite recent setbacks, the ophthalmology market still offers vast potential, says GlobalData

Despite the ophthalmology market experiencing several research and development (R&D) setbacks during 2018, the launch of three new drugs highlights that the mark...

Continue Reading →

Europe

MacroGenics breast cancer drug tops Herceptin in late-stage trial

Results from a late-stage study showed MacroGenics' experimental drug margetuximab extended progression-free survival in previously treated HER-2 positive metastatic...

7 February 2019 Europe | news | Regional News

Continue Reading →

Europe

CHMP recommends approval of Praluent® (alirocumab) to reduce cardiovascular risk in people with established atherosclerotic cardiovascular disease

PARIS and TARRYTOWN, NY - February 4, 2019 - The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for...

7 February 2019 Europe | news | North America | Regional News

Continue Reading →

Europe

Weak Q4 results and MS portfolio should be cause for concern for Biogen, says GlobalData

Following Biogen’s Q4 and full year 2018 earnings call (29 January), Antoine Grey, Pharma Analyst at GlobalData, a leading data and analytics company, offers his vie...

7 February 2019 Europe | news | Regional News

Continue Reading →